CoChat

Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent

Open access

The DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γδ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a−/− mice confirmed an essential role for IL-17A. Mechanistically, using ifnγ−/−, il10−/−, il10−/−il12p40−/−, and il10−/−il17a−/− mice and TGF-β blockade, we demonstrate that IL-17A–driven fibrosis is suppressed by IL-10 and facilitated by IFN-γ and IL-12/23p40. BLM-induced IL-17A production was also TGF-β dependent, and recombinant IL-17A–mediated fibrosis required TGF-β, suggesting cooperative roles for IL-17A and TGF-β in the development of fibrosis. Finally, we show that fibrosis induced by IL-1β, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1β were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20092121

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. IL-13–dependent and –independent pulmonary fibrosis. WT, il13−/−, or il13Rα2−/− mice were given either 5,000 S. mansoni eggs i.p. followed by 5,000 S. mansoni eggs i.v. 14 d later, with pulmonary fibrotic granulomas assessed 7 d later (d21; A and B), or an intratracheal delivery of 0.15 U BLM, with pulmonary fibrosis assessed on day 7 (C and D). One of two independent experiments is shown, with five animals per group. (A and C) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. Data shown are mean ± SEM. (B and D) 5-µm sections of paraffin-embedded lung tissue were stained with Masson’s Trichrome. Images are shown at 10× magnification. Collagen, blue; nuclei, dark red; cytoplasm, red/pink. Bars, 60 µm.
Figure 1. IL-13–dependent and –independent pulmonary fibrosis. WT, il13−/−, or il13Rα2−/− mice were given either 5,000 S. mansoni eggs i.p. followed by 5,000 S. mansoni eggs i.v. 14 d later, with pulmonary fibrotic granulomas assessed 7 d later (d21; A and B), or an intratracheal delivery of 0.15 U BLM, with pulmonary fibrosis assessed on day 7 (C and D). One of two independent experiments is shown, with five animals per group. (A and C) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. Data shown are mean ± SEM. (B and D) 5-µm sections of paraffin-embedded lung tissue were stained with Masson’s Trichrome. Images are shown at 10× magnification. Collagen, blue; nuclei, dark red; cytoplasm, red/pink. Bars, 60 µm.CC BY-NC-SA · PubMed Central
Figure 2. IL-17A and IFN-γ production during BLM-induced fibrosis. 0.15 U BLM was given to WT mice via intratracheal route, as in Fig. 1, with local immune profiling and assessment of tissue pathology analyzed from days 0 to 21, as indicated. One of three independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) Weight loss, assessed at several time points after BLM, as indicated. (B) Pulmonary collagen score from histology sections. (C) RNA was extracted from lung tissue, with timp-1, mmp12, and pro–COL-3 mRNA quantified by quantitative RT-PCR. (D) 5-µm sections of paraffin-embedded lung tissue obtained from mice at the indicated day after BLM and stained with Masson’s Trichrome. Images are shown at a 5× magnification. Bars, 60 µm. (E) BAL, lung, and lung-draining thoracic LN (t:LN) cells were isolated and stimulated with anti-CD3ε for 4 d. IL-17A, IFN-γ, and IL-13 were measured in culture supernatants by ELISA. (F) 5-µm sections of paraffin-embedded lung tissue obtained from mice at day 7 after BLM stained with Giemsa or Picrosirius red (inset) shown under polarized light. Images are shown at 10× magnification. Bars, 60 µm.
Figure 2. IL-17A and IFN-γ production during BLM-induced fibrosis. 0.15 U BLM was given to WT mice via intratracheal route, as in Fig. 1, with local immune profiling and assessment of tissue pathology analyzed from days 0 to 21, as indicated. One of three independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) Weight loss, assessed at several time points after BLM, as indicated. (B) Pulmonary collagen score from histology sections. (C) RNA was extracted from lung tissue, with timp-1, mmp12, and pro–COL-3 mRNA quantified by quantitative RT-PCR. (D) 5-µm sections of paraffin-embedded lung tissue obtained from mice at the indicated day after BLM and stained with Masson’s Trichrome. Images are shown at a 5× magnification. Bars, 60 µm. (E) BAL, lung, and lung-draining thoracic LN (t:LN) cells were isolated and stimulated with anti-CD3ε for 4 d. IL-17A, IFN-γ, and IL-13 were measured in culture supernatants by ELISA. (F) 5-µm sections of paraffin-embedded lung tissue obtained from mice at day 7 after BLM stained with Giemsa or Picrosirius red (inset) shown under polarized light. Images are shown at 10× magnification. Bars, 60 µm.CC BY-NC-SA · PubMed Central
Figure 3. IL-10–producing CD4 cells accumulate in the lung. 0.15 U BLM was given to C57BL/6 IL-10gfp mice via intratracheal route, as in Fig. 1. One of two independent experiments shown with five animals per group. Data shown are mean ± SEM. (A) Lung, BAL, or thoracic LN cells were isolated from IL-10gfp reporter mice and stained with anti–mouse CD3 and CD4. Horizontal bars show the mean. (B) CD4+IL-10gfp− and CD4+IL-10gfp+ cells were FACS sorted (>98% pure) from the lung of BLM-treated mice at day 7. RNA was extracted and analyzed for mRNA transcripts. The dotted line refers to naive CD4+ cells.
Figure 3. IL-10–producing CD4 cells accumulate in the lung. 0.15 U BLM was given to C57BL/6 IL-10gfp mice via intratracheal route, as in Fig. 1. One of two independent experiments shown with five animals per group. Data shown are mean ± SEM. (A) Lung, BAL, or thoracic LN cells were isolated from IL-10gfp reporter mice and stained with anti–mouse CD3 and CD4. Horizontal bars show the mean. (B) CD4+IL-10gfp− and CD4+IL-10gfp+ cells were FACS sorted (>98% pure) from the lung of BLM-treated mice at day 7. RNA was extracted and analyzed for mRNA transcripts. The dotted line refers to naive CD4+ cells.CC BY-NC-SA · PubMed Central
Figure 4. IL-10 restricts IL-17A and IFN-γ and the extent of pulmonary fibrosis. 0.15 U BLM was given to WT, IL-10gfp, or il10−/− mice, via the intratracheal route, as in Fig. 1. *, P < 0.05 using a Mann-Whitney test. One of three independent experiments is shown with five animals per group. Data shown are mean ± SEM. (A) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (B) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A or IFN-γ measured in culture supernatants. BAL collagen was quantified from BAL fluid using Sircol assay. (C) Lung cells, isolated at day 7 after BLM, were stained with anti–mouse, CD4, CD8, B220, γδTCR, NK1.1, IL-17A, and IFN-γ, after a brief stimulation with PMA and ionomycin in the presence of BFA. The percentage of CD4+ or γδ+ cells producing IL-17A, in addition to the total number of cells recovered from the lungs, is enumerated in the table. (D) Homogenized lung supernatant was assayed by ELISA for the indicated cytokines/chemokines.
Figure 4. IL-10 restricts IL-17A and IFN-γ and the extent of pulmonary fibrosis. 0.15 U BLM was given to WT, IL-10gfp, or il10−/− mice, via the intratracheal route, as in Fig. 1. *, P < 0.05 using a Mann-Whitney test. One of three independent experiments is shown with five animals per group. Data shown are mean ± SEM. (A) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (B) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A or IFN-γ measured in culture supernatants. BAL collagen was quantified from BAL fluid using Sircol assay. (C) Lung cells, isolated at day 7 after BLM, were stained with anti–mouse, CD4, CD8, B220, γδTCR, NK1.1, IL-17A, and IFN-γ, after a brief stimulation with PMA and ionomycin in the presence of BFA. The percentage of CD4+ or γδ+ cells producing IL-17A, in addition to the total number of cells recovered from the lungs, is enumerated in the table. (D) Homogenized lung supernatant was assayed by ELISA for the indicated cytokines/chemokines.CC BY-NC-SA · PubMed Central
Figure 5. IL-12/23p40 deficiency significantly impacts IL-17A and IFN-γ and curtails pulmonary fibrosis. 0.15 U BLM was given to WT, il10−/−, il12/23p40−/−, or il10−/−il12/23p40−/− mice via the intratracheal route as in Fig. 1. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) 5-µm sections of paraffin-embedded lung tissue taken from WT or il10−/− mice at day 7 or 21 after BLM and stained with Masson’s Trichrome. Images are shown at 5× magnification with dotted squares magnified at 40× in the insets. Bars: 60 µm; (inset) 7 µm. (B) Lung injury, measured as BAL collagen, was quantified from BAL fluid using Sircol assay. (C) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (D) Absolute counts of circulating poly morphonuclear cells (PMNs) were obtained from CBC counts. (E and F) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A (E) and IFN-γ (F) measured in cultures supernatants. (G) Thoracic LN cells were stained with anti–mouse CD4, CD8, B220, γδTCR, NK1.1, IL-17A, and IFN-γ after a brief stimulation with PMA and ionomycin in the presence of BFA. Data shown is gated on CD4+ cells.
Figure 5. IL-12/23p40 deficiency significantly impacts IL-17A and IFN-γ and curtails pulmonary fibrosis. 0.15 U BLM was given to WT, il10−/−, il12/23p40−/−, or il10−/−il12/23p40−/− mice via the intratracheal route as in Fig. 1. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) 5-µm sections of paraffin-embedded lung tissue taken from WT or il10−/− mice at day 7 or 21 after BLM and stained with Masson’s Trichrome. Images are shown at 5× magnification with dotted squares magnified at 40× in the insets. Bars: 60 µm; (inset) 7 µm. (B) Lung injury, measured as BAL collagen, was quantified from BAL fluid using Sircol assay. (C) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (D) Absolute counts of circulating poly morphonuclear cells (PMNs) were obtained from CBC counts. (E and F) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A (E) and IFN-γ (F) measured in cultures supernatants. (G) Thoracic LN cells were stained with anti–mouse CD4, CD8, B220, γδTCR, NK1.1, IL-17A, and IFN-γ after a brief stimulation with PMA and ionomycin in the presence of BFA. Data shown is gated on CD4+ cells.CC BY-NC-SA · PubMed Central
Figure 6. Attenuated pulmonary fibrosis in il17a−/− mice. 0.15 U BLM was given to WT, il10−/−, il17a−/−, or il10−/−il17a−/− mice, via the intratracheal route, as in Fig. 1. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) Lung injury, measured as BAL collagen, was quantified from BAL fluid using Sircol assay. (B) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (C) Absolute counts of circulating polymorphonuclear cells were obtained from CBC counts. (D) Percentage of weight change, 7 d after BLM. (E) 5-µm sections of paraffin-embedded lung tissue taken from WT or il10−/− mice at day 7 or 21 after BLM and stained with Masson’s Trichrome. Images are shown at a 40× magnification. Bar, 7 µm. (F) RNA was extracted from lung tissue, with indicated mRNA quantified by quantitative RT-PCR. (G and H) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A (G) and IFN-γ (H) measured in culture supernatants. (I) MMP2 and MMP9 bioactivity measured in BAL by zymography.
Figure 6. Attenuated pulmonary fibrosis in il17a−/− mice. 0.15 U BLM was given to WT, il10−/−, il17a−/−, or il10−/−il17a−/− mice, via the intratracheal route, as in Fig. 1. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) Lung injury, measured as BAL collagen, was quantified from BAL fluid using Sircol assay. (B) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (C) Absolute counts of circulating polymorphonuclear cells were obtained from CBC counts. (D) Percentage of weight change, 7 d after BLM. (E) 5-µm sections of paraffin-embedded lung tissue taken from WT or il10−/− mice at day 7 or 21 after BLM and stained with Masson’s Trichrome. Images are shown at a 40× magnification. Bar, 7 µm. (F) RNA was extracted from lung tissue, with indicated mRNA quantified by quantitative RT-PCR. (G and H) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A (G) and IFN-γ (H) measured in culture supernatants. (I) MMP2 and MMP9 bioactivity measured in BAL by zymography.CC BY-NC-SA · PubMed Central
Figure 7. IL-17A–dependent IL-1β–induced collagen deposition. Mice were given intratracheal 0.15 U BLM, 1 µg IL-1β, 1 µg IL-17A, or 0.5 µg each of both IL-1β and IL-17A with pulmonary collagen deposition assessed on day 7. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A and E) 5-µm sections of paraffin-embedded lung tissue were stained with Masson’s Trichrome. Images are shown at a 20× magnification. Bars, 20 µm. (B and F) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (C and I) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A and IFN-γ measured in culture supernatants. (D) MMP2 bioactivity in BAL fluid measured by zymography. (G) Absolute counts of circulating polymorphonuclear cells were obtained from CBC counts. (H) BAL fluid TIMP-1 and IFN-γ was measured by ELISA.
Figure 7. IL-17A–dependent IL-1β–induced collagen deposition. Mice were given intratracheal 0.15 U BLM, 1 µg IL-1β, 1 µg IL-17A, or 0.5 µg each of both IL-1β and IL-17A with pulmonary collagen deposition assessed on day 7. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A and E) 5-µm sections of paraffin-embedded lung tissue were stained with Masson’s Trichrome. Images are shown at a 20× magnification. Bars, 20 µm. (B and F) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (C and I) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A and IFN-γ measured in culture supernatants. (D) MMP2 bioactivity in BAL fluid measured by zymography. (G) Absolute counts of circulating polymorphonuclear cells were obtained from CBC counts. (H) BAL fluid TIMP-1 and IFN-γ was measured by ELISA.CC BY-NC-SA · PubMed Central
Figure 8. IL-17A–dependent fibrosis requires TGF-β. Mice were given 0.15 U of intratracheal BLM or 1 µg IL-17A with or without 500 µg of anti–TGF-β treatment on days −1, 3, and 5. Pulmonary collagen deposition was assessed on day 7. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) Lung injury, measured as BAL collagen, was quantified from BAL fluid using Sircol assay. (B) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (C) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A and IFN-γ measured in culture supernatants. (D) 5-µm sections of paraffin-embedded lung tissue were stained with Masson’s Trichrome. Images are shown at a 20× magnification. Bars, 20 µm.
Figure 8. IL-17A–dependent fibrosis requires TGF-β. Mice were given 0.15 U of intratracheal BLM or 1 µg IL-17A with or without 500 µg of anti–TGF-β treatment on days −1, 3, and 5. Pulmonary collagen deposition was assessed on day 7. *, P < 0.05 using a Mann-Whitney test. One of two independent experiments is shown, with five animals per group. Data shown are mean ± SEM. (A) Lung injury, measured as BAL collagen, was quantified from BAL fluid using Sircol assay. (B) Pulmonary collagen deposition, expressed as micromoles of hydroxyproline per lung. (C) Thoracic LN cells were stimulated with anti-CD3ε, with IL-17A and IFN-γ measured in culture supernatants. (D) 5-µm sections of paraffin-embedded lung tissue were stained with Masson’s Trichrome. Images are shown at a 20× magnification. Bars, 20 µm.CC BY-NC-SA · PubMed Central
Figure 9. Elevated IL-17A and IL-1β in human IPF patient BAL fluid. BAL fluid and lung biopsies were collected from NVs and IPF patients. (A) BAL fluid was assayed for IL-17A and IL-1β by ELISA. (B) 5-µm lung sections were cut from paraffin-embedded lung biopsies and stained with Masson’s trichrome. Data shown are mean ± SEM. Images are shown at 5× (top) and dashed rectangles are magnified at 20× (bottom). Bars: (top) 60 µm; (bottom) 20 µm.
Figure 9. Elevated IL-17A and IL-1β in human IPF patient BAL fluid. BAL fluid and lung biopsies were collected from NVs and IPF patients. (A) BAL fluid was assayed for IL-17A and IL-1β by ELISA. (B) 5-µm lung sections were cut from paraffin-embedded lung biopsies and stained with Masson’s trichrome. Data shown are mean ± SEM. Images are shown at 5× (top) and dashed rectangles are magnified at 20× (bottom). Bars: (top) 60 µm; (bottom) 20 µm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 751

Metadata

Authors
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A.
Affiliations
  • National Institutes of Health (US)
  • Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 3
  • Biomedical Research Institute (US)
Corresponding author
Wynn, Thomas A.
Venue
Journal of Experimental Medicine
Published
2010-02-22
Volume
207
Issue
3
Pages
535-552
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2095715691
Cited by
730
References
84
Citations by year
2026: 28 · 2025: 39 · 2024: 68 · 2023: 45 · 2022: 47 · 2021: 39 · 2020: 38 · 2019: 51 · 2018: 47 · 2017: 48 · 2016: 42 · 2015: 42 · 2014: 40 · 2013: 57 · 2012: 45
FWCI
41.61
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
idiopathic pulmonary fibrosis, IL-17A, bleomycin-induced lung injury, IL-1β, pulmonary fibrosis, TGF-beta, IL-10, interferon-gamma, IL-12/23p40, γδ T cells, CD4+ T cells, neutrophilia, Schistosoma mansoni eggs, bronchoalveolar lavage, IL-17A blockade
MeSH terms
Animals, Bleomycin, Interferon-gamma, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Schistosoma mansoni, Schistosomiasis mansoni, CD4-Positive T-Lymphocytes, Interleukin-10, Mice, Knockout, Interleukin-13, Interleukin-17, Mice, Interleukin-1beta, Interleukin-12 Subunit p40

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.